Tryptophan

Tryptophan

SCHEMBL6839093

N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O.N[C@@H](Cc1ccccc1)C(=O)O.O=C(O)[C@@H]1CCCN1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Tryptophan. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.64
KDM4E B2RXH2 3/20 0.64
MAPT P10636 3/20 0.64
MEN1 O00255 2/20 0.64
LMNA P02545 2/20 0.64
TSHR P16473 2/20 0.64
BLM P54132 2/20 0.64
PMP22 Q01453 2/20 0.64
MPO P05164 1/20 0.64
HIF1A Q16665 1/20 0.64
HSP90AA1 P07900 1/20 0.49
HSP90AB1 P08238 1/20 0.49
LTA4H P09960 1/20 0.49
PLA2G2A P14555 1/20 0.49
DPP4 P27487 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP3A4 P08684 1/20 0.47
HTR1A P08908 1/20 0.47
ADORA3 P0DMS8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dl-Tryptophan SCHEMBL23924434 1.00 KMT2A (0.64) KMT2AKDM4EMAPTMEN1LMNA
Tryptophan SCHEMBL5062089 0.96 KDM4E (0.70) KMT2AKDM4EMAPTMEN1LMNA
Tryptophan SCHEMBL2323821 0.96 KDM4E (0.70) KMT2AKDM4EMAPTMEN1LMNA
Dl-Tryptophan SCHEMBL28152577 0.96 KDM4E (0.70) KMT2AKDM4EMAPTMEN1LMNA
Dl-Tryptophan SCHEMBL23722672 0.96 KDM4E (0.70) KMT2AKDM4EMAPTMEN1LMNA
Tryptophan SCHEMBL2723276 0.96 KDM4E (0.70) KMT2AKDM4EMAPTMEN1LMNA
Tryptophan SCHEMBL1839832 0.96 KDM4E (0.70) KMT2AKDM4EMAPTMEN1LMNA
Dl-Tryptophan SCHEMBL23931432 0.96 KDM4E (0.70) KMT2AKDM4EMAPTMEN1LMNA
Dl-Tryptophan SCHEMBL1839831 0.96 KDM4E (0.70) KMT2AKDM4EMAPTMEN1LMNA
Dl-Tryptophan SCHEMBL29015084 0.95 KDM4E (0.58) KMT2AKDM4EMAPTMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2756076-B1 ENZYME VARIANTS WITH IMPROVED PROPERTIES METGEN OY (FI) 2017-04-26 EP claimed
US-20170081643-A1 LACCASE VARIANTS HAVING INCREASED ACTIVITY IN ALKALINE CONDITIONS METGEN OY (FI) 2017-03-23 US claimed
EP-2756076-A1 ENZYME VARIANTS WITH IMPROVED PROPERTIES MetGen Oy (FI) 2014-07-23 EP claimed
WO-2013038062-A1 ENZYME VARIANTS WITH IMPROVED PROPERTIES METGEN OY (FI) 2013-03-21 WO claimed
EP-2756076-B1 ENZYME VARIANTS WITH IMPROVED PROPERTIES METGEN OY (FI) 2017-04-26 EP disclosed
US-20170081643-A1 LACCASE VARIANTS HAVING INCREASED ACTIVITY IN ALKALINE CONDITIONS METGEN OY (FI) 2017-03-23 US disclosed
US-20150159144-A1 ENZYME VARIANTS WITH IMPROVED PROPERTIES METGEN OY (FI) 2015-06-11 US disclosed
EP-2756076-A1 ENZYME VARIANTS WITH IMPROVED PROPERTIES MetGen Oy (FI) 2014-07-23 EP disclosed
WO-2013038062-A1 ENZYME VARIANTS WITH IMPROVED PROPERTIES METGEN OY (FI) 2013-03-21 WO disclosed
US-20040191911-A1 Method for altering degradation of engineered protein in plant cells NELSON RICHARD S (US) 2004-09-30 US disclosed
EP-1309708-A2 METHOD FOR ALTERING DEGRADATION OF ENGINEERED PROTEIN IN PLANT CELLS THE SAMUEL ROBERTS NOBLE FOUNDATION, INC. (US) 2003-05-14 EP disclosed
WO-2002006501-A2 METHOD FOR ALTERING DEGRADATION OF ENGINEERED PROTEIN IN PLANT CELLS THE SAMUEL ROBERTS NOBLE FOUNDATION, INC. (US) 2002-01-24 WO disclosed